Loss of the Transcriptional Repressor PAG-3/Gfi-1 Results in Enhanced Neurosecretion that is Dependent on the Dense-Core Vesicle Membrane Protein IDA-1/IA-2
It is generally accepted that neuroendocrine cells regulate dense core vesicle (DCV) biogenesis and cargo packaging in response to secretory demands, although the molecular mechanisms of this process are poorly understood. One factor that has previously been implicated in DCV regulation is IA-2, a catalytically inactive protein phosphatase present in DCV membranes. Our ability to directly visualize a functional, GFP-tagged version of an IA-2 homolog in live Caenorhabditis elegans animals has allowed us to capitalize on the genetics of the system to screen for mutations that disrupt DCV regulation. We found that loss of activity in the transcription factor PAG-3/Gfi-1, which functions as a repressor in many systems, results in a dramatic up-regulation of IDA-1/IA-2 and other DCV proteins. The up-regulation of DCV components was accompanied by an increase in presynaptic DCV numbers and resulted in phenotypes consistent with increased neuroendocrine secretion. Double mutant combinations revealed that these PAG-3 mutant phenotypes were dependent on wild type IDA-1 function. Our results support a model in which IDA-1/IA-2 is a critical element in DCV regulation and reveal a novel genetic link to PAG-3-mediated transcriptional regulation. To our knowledge, this is the first mutation identified that results in increased neurosecretion, a phenotype that has clinical implications for DCV-mediated secretory disorders.
References
[1]
Kim T, Gondre-Lewis MC, Arnaoutova I, Loh YP (2006) Dense-core secretory granule biogenesis. Physiology (Bethesda) 21: 124–133.
[2]
Borgonovo B, Ouwendijk J, Solimena M (2006) Biogenesis of secretory granules. Curr Opin Cell Biol 18: 365–370.
[3]
Notkins AL (2002) Immunologic and genetic factors in type 1 diabetes. J Biol Chem 277: 43545–43548.
[4]
Lan MS, Lu J, Goto Y, Notkins AL (1994) Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13: 505–514.
[5]
Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, et al. (1996) Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A 93: 2307–2311.
[6]
Wasmeier C, Hutton JC (1996) Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem 271: 18161–18170.
[7]
Cai T, Krause MW, Odenwald WF, Toyama R, Notkins AL (2001) The IA-2 gene family: homologs in Caenorhabditis elegans, Drosophila and zebrafish. Diabetologia 44: 81–88.
[8]
Magistrelli G, Toma S, Isacchi A (1996) Substitution of two variant residues in the protein tyrosine phosphatase-like PTP35/IA-2 sequence reconstitutes catalytic activity. Biochem Biophys Res Commun 227: 581–588.
[9]
Hermel JM, Dirkx R, Solimena M (1999) Post-translational modifications of ICA512, a receptor tyrosine phosphatase-like protein of secretory granules. Eur J Neurosci 11: 2609–2620.
[10]
Saeki K, Zhu M, Kubosaki A, Xie J, Lan MS, et al. (2002) Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion. Diabetes 51: 1842–1850.
[11]
Kubosaki A, Gross S, Miura J, Saeki K, Zhu M, et al. (2004) Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice. Diabetes 53: 1684–1691.
[12]
Kubosaki A, Nakamura S, Notkins AL (2005) Dense Core Vesicle Proteins IA-2 and IA-2{beta}: Metabolic Alterations in Double Knockout Mice. Diabetes 54: Suppl 2S46–51.
[13]
Kubosaki A, Nakamura S, Clark A, Morris JF, Notkins AL (2005) Disruption of the Transmembrane Dense Core Vesicle Proteins IA-2 and IA-2{beta} Causes Female Infertility. Endocrinology.
[14]
Harashima S, Clark A, Christie MR, Notkins AL (2005) The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion. Proc Natl Acad Sci U S A 102: 8704–8709.
[15]
Mziaut H, Trajkovski M, Kersting S, Ehninger A, Altkruger A, et al. (2006) Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5. Nat Cell Biol 8: 435–445.
[16]
Rand JB, Nonet ML (1997) Synaptic transmission. In: Riddle DL, Blumenthal T, Meyer BJ, Priess JR, editors. C elegans II. Plainview: Cold Spring Harbor Laboratory Press. pp. 611–644.
[17]
Chalfie M, Jorgensen EM (1998) C. elegans neuroscience: genetics to genome. Trends Genet 14: 506–512.
[18]
Cai T, Fukushige T, Notkins AL, Krause M (2004) Insulinoma-Associated Protein IA-2, a Vesicle Transmembrane Protein, Genetically Interacts with UNC-31/CAPS and Affects Neurosecretion in Caenorhabditis elegans. J Neurosci 24: 3115–3124.
[19]
Zahn TR, Angleson JK, MacMorris MA, Domke E, Hutton JF, et al. (2004) Dense core vesicle dynamics in Caenorhabditis elegans neurons and the role of kinesin UNC-104. Traffic 5: 544–559.
[20]
Sieburth D, Madison JM, Kaplan JM (2007) PKC-1 regulates secretion of neuropeptides. Nat Neurosci 10: 49–57.
[21]
Zhou KM, Dong YM, Ge Q, Zhu D, Zhou W, et al. (2007) PKA activation bypasses the requirement for UNC-31 in the docking of dense core vesicles from C. elegans neurons. Neuron 56: 657–669.
[22]
Mahoney TR, Luo S, Nonet ML (2006) Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay. Nat Protoc 1: 1772–1777.
Zahn TR, Macmorris MA, Dong W, Day R, Hutton JC (2001) IDA-1, a Caenorhabditis elegans homolog of the diabetic autoantigens IA-2 and phogrin, is expressed in peptidergic neurons in the worm. J Comp Neurol 429: 127–143.
[25]
Sulston JE, Horvitz HR (1977) Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 56: 110–156.
[26]
Cameron S, Clark SG, McDermott JB, Aamodt E, Horvitz HR (2002) PAG-3, a Zn-finger transcription factor, determines neuroblast fate in C. elegans. Development 129: 1763–1774.
[27]
Conradt B, Xue D (2005) Programmed cell death. WormBook 1–13.
[28]
Jia Y, Xie G, McDermott JB, Aamodt E (1997) The C. elegans gene pag-3 is homologous to the zinc finger proto-oncogene gfi-1. Development 124: 2063–2073.
[29]
Duerr JS, Frisby DL, Gaskin J, Duke A, Asermely K, et al. (1999) The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J Neurosci 19: 72–84.
[30]
Nonet ML, Grundahl K, Meyer BJ, Rand JB (1993) Synaptic function is impaired but not eliminated in C. elegans mutants lacking synaptotagmin. Cell 73: 1291–1305.
Nonet ML, Saifee O, Zhao H, Rand JB, Wei L (1998) Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants. J Neurosci 18: 70–80.
[33]
Papini E, Rossetto O, Cutler DF (1995) Vesicle-associated membrane protein (VAMP)/synaptobrevin-2 is associated with dense core secretory granules in PC12 neuroendocrine cells. J Biol Chem 270: 1332–1336.
[34]
Nonet ML, Staunton JE, Kilgard MP, Fergestad T, Hartwieg E, et al. (1997) Caenorhabditis elegans rab-3 mutant synapses exhibit impaired function and are partially depleted of vesicles. J Neurosci 17: 8061–8073.
[35]
Speese S, Petrie M, Schuske K, Ailion M, Ann K, et al. (2007) UNC-31 (CAPS) is required for dense-core vesicle but not synaptic vesicle exocytosis in Caenorhabditis elegans. J Neurosci 27: 6150–6162.
[36]
Charlie NK, Schade MA, Thomure AM, Miller KG (2006) Presynaptic UNC-31 (CAPS) is required to activate the G alpha(s) pathway of the Caenorhabditis elegans synaptic signaling network. Genetics 172: 943–961.
[37]
Horvitz HR, Chalfie M, Trent C, Sulston JE, Evans PD (1982) Serotonin and octopamine in the nematode Caenorhabditis elegans. Science 216: 1012–1014.
[38]
Waggoner LE, Zhou GT, Schafer RW, Schafer WR (1998) Control of alternative behavioral states by serotonin in Caenorhabditis elegans. Neuron 21: 203–214.
[39]
Nguyen M, Alfonso A, Johnson CD, Rand JB (1995) Caenorhabditis elegans mutants resistant to inhibitors of acetylcholinesterase. Genetics 140: 527–535.
[40]
Jorgensen EM, Hartwieg E, Schuske K, Nonet ML, Jin Y, et al. (1995) Defective recycling of synaptic vesicles in synaptotagmin mutants of Caenorhabditis elegans. Nature 378: 196–199.
[41]
Jacob TC, Kaplan JM (2003) The EGL-21 carboxypeptidase E facilitates acetylcholine release at Caenorhabditis elegans neuromuscular junctions. J Neurosci 23: 2122–2130.
[42]
Miller KG, Alfonso A, Nguyen M, Crowell JA, Johnson CD, et al. (1996) A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc Natl Acad Sci U S A 93: 12593–12598.
[43]
Li W, Kennedy SG, Ruvkun G (2003) daf-28 encodes a C. elegans insulin superfamily member that is regulated by environmental cues and acts in the DAF-2 signaling pathway. Genes Dev 17: 844–858.
[44]
Miller DM, Shen MM, Shamu CE, Burglin TR, Ruvkun G, et al. (1992) C. elegans unc-4 gene encodes a homeodomain protein that determines the pattern of synaptic input to specific motor neurons. Nature 355: 841–845.
[45]
Lickteig KM, Duerr JS, Frisby DL, Hall DH, Rand JB, et al. (2001) Regulation of neurotransmitter vesicles by the homeodomain protein UNC-4 and its transcriptional corepressor UNC-37/groucho in Caenorhabditis elegans cholinergic motor neurons. J Neurosci 21: 2001–2014.
[46]
Sze JY, Zhang S, Li J, Ruvkun G (2002) The C. elegans POU-domain transcription factor UNC-86 regulates the tph-1 tryptophan hydroxylase gene and neurite outgrowth in specific serotonergic neurons. Development 129: 3901–3911.
[47]
Kim K, Li C (2004) Expression and regulation of an FMRFamide-related neuropeptide gene family in Caenorhabditis elegans. J Comp Neurol 475: 540–550.
[48]
Goto Y, De Silva MG, Toscani A, Prabhakar BS, Notkins AL, et al. (1992) A novel human insulinoma-associated cDNA, IA-1, encodes a protein with “zinc-finger” DNA-binding motifs. J Biol Chem 267: 15252–15257.
[49]
Xie J, Cai T, Zhang H, Lan MS, Notkins AL (2002) The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the Cbl-associated protein. Genomics 80: 54–61.
[50]
Gierl MS, Karoulias N, Wende H, Strehle M, Birchmeier C (2006) The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells. Genes Dev 20: 2465–2478.
[51]
Ort T, Voronov S, Guo J, Zawalich K, Froehner SC, et al. (2001) Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion. EMBO J 20: 4013–4023.
[52]
Trajkovski M, Mziaut H, Altkruger A, Ouwendijk J, Knoch KP, et al. (2004) Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in {beta}-cells. J Cell Biol 167: 1063–1074.
[53]
Gorogawa S, Fujitani Y, Kaneto H, Hazama Y, Watada H, et al. (2004) Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice. Biochem Biophys Res Commun 319: 1159–1170.
[54]
Lee JYJ-Y, Gavrilova OO, Davani BB, Na RR, Robinson GWGW, et al. (2007) The transcription factors Stat5a/b are not required for islet development but modulate pancreatic beta-cell physiology upon aging. Biochimica et biophysica acta 1773: 1455–1461.
[55]
Gilks CB, Bear SE, Grimes HL, Tsichlis PN (1993) Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol 13: 1759–1768.
[56]
Nolo R, Abbott LA, Bellen HJ (2000) Senseless, a Zn finger transcription factor, is necessary and sufficient for sensory organ development in Drosophila. Cell 102: 349–362.
[57]
Hock H, Orkin SH (2006) Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cells. Curr Opin Hematol 13: 1–6.
[58]
Prasad B, Karakuzu O, Reed RR, Cameron S (2008) unc-3-dependent repression of specific motor neuron fates in Caenorhabditis elegans. Dev Biol 323: 207–215.
[59]
Zweidler-Mckay PA, Grimes HL, Flubacher MM, Tsichlis PN (1996) Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 16: 4024–4034.
[60]
Kazanjian A, Wallis D, Au N, Nigam R, Venken KJ, et al. (2004) Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells. Cancer Res 64: 6874–6882.
[61]
Linnoila RI, Jensen-Taubman S, Kazanjian A, Grimes HL (2007) Loss of GFI1 impairs pulmonary neuroendorine cell proliferation, but the neuroendocrine phenotype has limited impact on post-naphthalene airway repair. Lab Invest 87: 336–344.
[62]
Kazanjian A, Gross EA, Grimes HL (2006) The growth factor independence-1 transcription factor: new functions and new insights. Crit Rev Oncol Hematol 59: 85–97.
[63]
Xie H, Notkins AL, Lan MS (1996) IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype. Cancer Res 56: 2742–2744.
[64]
Lu J, Li Q, Donadel G, Notkins AL, Lan MS (1998) Profile and differential expression of protein tyrosine phosphatases in mouse pancreatic islet tumor cell lines. Pancreas 16: 515–520.
[65]
Cunningham JJL, Lopez-Egido JJR, Janson EET, Eriksson BB, Oberg KK, et al. (2000) Transmembrane protein tyrosine phosphatase IA-2 (ICA512) is expressed in human midgut carcinoids but is not detectable in normal enterochromaffin cells. The Journal of endocrinology 164: 315–322.
[66]
Ide A, Ashizawa K, Ishikawa N, Ishii R, Ando T, et al. (2001) Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma. Thyroid 11: 1055–1061.
[67]
Balaton AJ, Galet BA (1998) Detection of chromogranin A mRNA in small cell lung carcinoma using a new, highly sensitive in situ hybridization method with a non-radioisotope oligonucleotide probe. Cancer 83: 1469–1470.
[68]
Radulescu D, Pripon S, Bunea D, Ciuleanu TE, Radulescu LI (2007) Endocrine paraneoplastic syndromes in small cell lung carcinoma. Two case reports. J Buon 12: 411–414.
[69]
Kiaris H, Schally AV, Varga JL, Groot K, Armatis P (1999) Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma. Proc Natl Acad Sci U S A 96: 14894–14898.
[70]
Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94.
[71]
Iwasaki K, Toyonaga R (2000) The Rab3 GDP/GTP exchange factor homolog AEX-3 has a dual function in synaptic transmission. Embo J 19: 4806–4816.
[72]
Trent C, Tsuing N, Horvitz HR (1983) Egg-laying defective mutants of the nematode Caenorhabditis elegans. Genetics 104: 619–647.
[73]
Miller KG, Emerson MD, Rand JB (1999) Goalpha and diacylglycerol kinase negatively regulate the Gqalpha pathway in C. elegans. Neuron 24: 323–333.
[74]
Ailion M, Thomas JH (2000) Dauer formation induced by high temperatures in Caenorhabditis elegans. Genetics 156: 1047–1067.
[75]
Wicks SR, Yeh RT, Gish WR, Waterston RH, Plasterk RH (2001) Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat Genet 28: 160–164.
[76]
Koch R, van Luenen HG, van der Horst M, Thijssen KL, Plasterk RH (2000) Single nucleotide polymorphisms in wild isolates of Caenorhabditis elegans. Genome Res 10: 1690–1696.
[77]
Li Y, Kelly WG, Logsdon JM Jr, Schurko AM, Harfe BD, et al. (2004) Functional genomic analysis of the ADP-ribosylation factor family of GTPases: phylogeny among diverse eukaryotes and function in C. elegans. Faseb J 18: 1834–1850.
[78]
Kass J, Jacob TC, Kim P, Kaplan JM (2001) The EGL-3 proprotein convertase regulates mechanosensory responses of Caenorhabditis elegans. J Neurosci 21: 9265–9272.
[79]
Rosoff ML, Doble KE, Price DA, Li C (1993) The flp-1 propeptide is processed into multiple, highly similar FMRFamide-like peptides in Caenorhabditis elegans. Peptides 14: 331–338.
[80]
Pierce SB, Costa M, Wisotzkey R, Devadhar S, Homburger SA, et al. (2001) Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev 15: 672–686.
[81]
Li C, Nelson LS, Kim K, Nathoo A, Hart AC (1999) Neuropeptide gene families in the nematode Caenorhabditis elegans. Ann N Y Acad Sci 897: 239–252.
[82]
Yamamoto H, Matsumoto K, Araki E, Miyamoto E (2003) New aspects of neurotransmitter release and exocytosis: involvement of Ca2+/calmodulin-dependent phosphorylation of synapsin I in insulin exocytosis. J Pharmacol Sci 93: 30–34.
[83]
Knaus P, Marqueze-Pouey B, Scherer H, Betz H (1990) Synaptoporin, a novel putative channel protein of synaptic vesicles. Neuron 5: 453–462.
[84]
Albertson DG (1985) Mapping muscle protein genes by in situ hybridization using biotin-labeled probes. Embo J 4: 2493–2498.
[85]
Phillips JB, Lyczak R, Ellis GC, Bowerman B (2004) Roles for two partially redundant alpha-tubulins during mitosis in early Caenorhabditis elegans embryos. Cell Motil Cytoskeleton 58: 112–126.
